Clinical benefit with SGLT2 inhibitor in diabetes patients with HF independent of ejection fraction3' education - Apr. 8, 2019 - Dr. Eri Kato, Kyoto, Japan
This video was recorded at the Congress of the American College of Cardiology (ACC) 2019.
Dr. Eri Kato is Cardiologist and researcher at the University of Kyoto in Japan.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.